查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1703295

乳膠凝集檢測試劑盒市場－全球產業規模、佔有率、趨勢、機會和預測，按產品類型、按測試類型、按樣本類型、按最終用戶、按地區和競爭情況細分，2020 年至 2030 年

Latex Agglutination Test Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Test Type, By Sample Type, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球乳膠凝集檢測試劑盒市值為 6.1254 億美元，預計到 2030 年將達到 8.1412 億美元，預測期內年複合成長率(CAGR) 為 4.86%。

市場概覽
預測期 2026-2030
2024年市場規模 6.1254億美元
2030年市場規模 8.1412億美元
2025-2030 年複合年成長率 4.86%
成長最快的領域 血
最大的市場 北美洲

乳膠凝集試驗廣泛用於臨床診斷，以檢測生物樣本中的特定抗原或抗體。這些測試因其速度快、可靠性高和成本效益高而受到認可，經常用於診斷傳染病、自體免疫疾病和其他醫療狀況。這些試劑盒在分析腦脊髓液等體液方面特別有效，並且由於其在疾病檢測和管理中的實用性而得到越來越廣泛的採用。

關鍵市場促進因素

傳染病發生率上升

主要市場挑戰

解釋複雜性

主要市場趨勢

與數位解決方案整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球乳膠凝集測試試劑盒市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型（ELISA、間接螢光、血凝抑制、血清中和）
    • 依檢測類型（抗體檢測、抗原檢測）
    • 依樣本類型（血液、尿液、腦脊髓液、其他）
    • 按最終用戶（醫院藥局、零售藥局、網路藥局）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 市場地圖
  • 依產品類型
  • 按測試類型
  • 依樣本類型
  • 按最終用戶
  • 按地區

第6章：北美乳膠凝集檢測試劑盒市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲乳膠凝集檢測試劑盒市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太乳膠凝集檢測試劑盒市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲乳膠凝集檢測試劑盒市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲乳膠凝集測試試劑盒市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球乳膠凝集測試套件市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Thermo Fisher Scientific, Inc.
  • Biomerieux SA
  • Biolegend, Inc.
  • Eurofins Scientific
  • Hardy Diagnostics
  • Himedia Laboratories
  • Biotec
  • Creative Diagnostics
  • ELITech Group
  • ARKRAY, Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 17097

Global Latex Agglutination Test Kits market was valued at USD 612.54 million in 2024 and is projected to reach USD 814.12 million by 2030, registering a compound annual growth rate (CAGR) of 4.86% over the forecast period.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 612.54 Million
Market Size 2030USD 814.12 Million
CAGR 2025-20304.86%
Fastest Growing SegmentBlood
Largest MarketNorth America

Latex agglutination tests are widely utilized in clinical diagnostics to detect specific antigens or antibodies in biological samples. Recognized for their speed, reliability, and cost-effectiveness, these tests are frequently employed in the diagnosis of infectious diseases, autoimmune disorders, and other medical conditions. These kits are particularly effective in analyzing body fluids such as cerebrospinal fluid and are seeing increased adoption due to their practical utility in disease detection and management.

Key Market Drivers

Rising Incidence of Infectious Diseases

The global upsurge in infectious diseases is significantly fueling demand for diagnostic testing. Latex agglutination tests offer a rapid, easy-to-use, and affordable method for disease detection, making them highly attractive for healthcare systems seeking efficient diagnostic solutions, particularly during outbreaks or pandemics. One of the key advantages of these tests is their ability to deliver results within minutes, facilitating early diagnosis and timely medical intervention. This is especially crucial in managing fast-spreading or highly contagious diseases, where early detection can be instrumental in preventing widespread transmission. Latex agglutination tests are also well-suited for point-of-care use, enabling healthcare professionals to conduct diagnostics at the bedside, in outpatient settings, or in remote locations lacking advanced laboratory infrastructure. This portability and ease of use make them ideal for decentralized healthcare delivery. In the context of public health surveillance, these tests contribute valuable data for tracking disease prevalence and informing resource allocation strategies. The growing incidence of infectious diseases is further stimulating research and innovation to enhance the sensitivity, specificity, and scope of latex agglutination diagnostics.

Key Market Challenges

Interpretation Complexity

One of the primary challenges facing the Latex Agglutination Test Kits market is the complexity associated with result interpretation. Misinterpretation due to the nuanced nature of these tests can result in diagnostic inaccuracies, potentially leading to delayed or inappropriate treatments. Effective utilization of these tests requires healthcare professionals to undergo adequate training. In resource-limited settings where access to training is constrained, the adoption of latex agglutination kits may be restricted. Moreover, concerns around the consistency and reproducibility of test results-particularly when different professionals interpret outcomes differently-can undermine confidence in the technology.

Complex interpretation may also complicate clinical decision-making, leading healthcare providers to opt for alternative diagnostic solutions perceived as more straightforward. The additional cost and time associated with training personnel can further act as a barrier to widespread adoption. Given their frequent use in point-of-care environments, where speed and simplicity are vital, any factor that detracts from these core benefits-such as interpretative complexity-can diminish their appeal. As a result, healthcare providers may favor diagnostic tools that offer clearer, faster, and more user-friendly outcomes.

Key Market Trends

Integration with Digital Solutions

The integration of latex agglutination test kits with digital health platforms is emerging as a transformative trend, enhancing the functionality and accessibility of these diagnostics. Real-time connectivity enables healthcare providers, patients, and stakeholders to access and share test results efficiently-particularly beneficial in point-of-care and remote settings. Digital integration also facilitates remote patient monitoring, allowing individuals to communicate test results with clinicians without requiring in-person visits, thereby streamlining care delivery and reducing costs. These platforms can capture and analyze vast datasets from test usage, generating insights into disease trends and supporting epidemiological research. Advanced digital tools can assist healthcare providers in interpreting test results through decision support algorithms, minimizing the likelihood of human error and improving diagnostic accuracy. Furthermore, telemedicine platforms benefit from this integration, as professionals can remotely review results and offer consultations, improving access to care in underserved areas. Patients, too, stand to benefit through improved engagement. Access to their test results via digital interfaces empowers them to take a more active role in managing their health, leading to better treatment adherence and improved outcomes.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Biomerieux SA
  • Biolegend, Inc.
  • Eurofins Scientific
  • Hardy Diagnostics
  • Himedia Laboratories
  • Biotec
  • Creative Diagnostics
  • ELITechGroup
  • ARKRAY, Inc.

Report Scope:

In this report, the Global Latex Agglutination Test Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Latex Agglutination Test Kits Market, By Product Type:

  • ELISA
  • Indirect Fluorescent
  • Hemagglutination Inhibition
  • Serum Neutralization

Latex Agglutination Test Kits Market, By Test Type:

  • Antibody Detection
  • Antigen Testing

Latex Agglutination Test Kits Market, By Sample Type:

  • Blood
  • Urine
  • Cerebrospinal Fluid
  • Others

Latex Agglutination Test Kits Market, By End User:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Latex Agglutination Test Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Latex Agglutination Test Kits Market.

Available Customizations:

Global Latex Agglutination Test Kits market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Latex Agglutination Test Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (ELISA, Indirect Fluorescent, Hemagglutination Inhibition, Serum Neutralization)
    • 5.2.2. By Test Type (Antibody Detection, Antigen Testing)
    • 5.2.3. By Sample Type (Blood, Urine, Cerebrospinal Fluid, Others)
    • 5.2.4. By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.6. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Product Type
  • 5.3.2 By Test Type
  • 5.3.3 By Sample Type
  • 5.3.4 By End User
  • 5.3.5 By Region

6. North America Latex Agglutination Test Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Test Type
    • 6.2.3. By Sample Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Latex Agglutination Test Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By Sample Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Latex Agglutination Test Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By Sample Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Latex Agglutination Test Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By Sample Type
        • 6.3.3.2.4. By End User

7. Europe Latex Agglutination Test Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Test Type
    • 7.2.3. By Sample Type
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Latex Agglutination Test Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Sample Type
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Latex Agglutination Test Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Sample Type
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Latex Agglutination Test Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Sample Type
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Latex Agglutination Test Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Sample Type
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Latex Agglutination Test Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Sample Type
        • 7.3.5.2.4. By End User

8. Asia-Pacific Latex Agglutination Test Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Test Type
    • 8.2.3. By Sample Type
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Latex Agglutination Test Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Sample Type
        • 8.3.1.2.4. By End User
    • 8.3.2. India Latex Agglutination Test Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Sample Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Latex Agglutination Test Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Sample Type
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Latex Agglutination Test Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By Sample Type
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Latex Agglutination Test Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By Sample Type
        • 8.3.5.2.4. By End User

9. South America Latex Agglutination Test Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Test Type
    • 9.2.3. By Sample Type
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Latex Agglutination Test Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Sample Type
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Latex Agglutination Test Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Sample Type
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Latex Agglutination Test Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Sample Type
        • 9.3.3.2.4. By End User

10. Middle East and Africa Latex Agglutination Test Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Test Type
    • 10.2.3. By Sample Type
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Latex Agglutination Test Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Sample Type
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Latex Agglutination Test Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Sample Type
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Latex Agglutination Test Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Sample Type
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Latex Agglutination Test Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Product Offerings
    • 15.1.4. Recent Developments
    • 15.1.5. Financials (As Reported)
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Biomerieux SA
  • 15.3. Biolegend, Inc.
  • 15.4. Eurofins Scientific
  • 15.5. Hardy Diagnostics
  • 15.6. Himedia Laboratories
  • 15.7. Biotec
  • 15.8. Creative Diagnostics
  • 15.9. ELITech Group
  • 15.10. ARKRAY, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer